Raymond James Financial Inc. Takes Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Raymond James Financial Inc. purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 70,341 shares of the company's stock, valued at approximately $6,240,000. Raymond James Financial Inc. owned 0.47% of U.S. Physical Therapy at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. BNP Paribas Financial Markets boosted its position in U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock worth $1,425,000 after purchasing an additional 12,445 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock valued at $223,000 after acquiring an additional 956 shares during the period. State Street Corp lifted its position in shares of U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after acquiring an additional 99,244 shares in the last quarter. Stifel Financial Corp boosted its holdings in shares of U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company's stock worth $4,838,000 after acquiring an additional 6,154 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of U.S. Physical Therapy by 1.3% in the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company's stock valued at $29,040,000 after purchasing an additional 4,477 shares in the last quarter.

Remove Ads

Analyst Upgrades and Downgrades

Several brokerages have commented on USPH. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. JMP Securities started coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an "outperform" rating and a $113.00 price target on the stock. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their price target for the company from $100.00 to $115.00 in a report on Monday, December 16th. Finally, StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Trading Down 0.5 %

USPH traded down $0.39 on Tuesday, hitting $73.26. 97,534 shares of the company were exchanged, compared to its average volume of 99,745. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a fifty day simple moving average of $84.54 and a two-hundred day simple moving average of $86.91. The stock has a market capitalization of $1.11 billion, a PE ratio of 77.94, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. U.S. Physical Therapy, Inc. has a 12 month low of $72.27 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a $0.45 dividend. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy's payout ratio is currently 97.83%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.